Position in GH
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$393,078
-$311,520 QoQ
Shares Held
2,620
-65.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#394
of 596 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026State of Wyoming holds $9,049,964 across 23 Diagnostics & Research names. GH ranks #4 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ICLR |
Icon PLC
|
22,228 | $3,861,225 | |
| 2 | SHC |
Sotera Health Co
|
56,651 | $1,005,555 | |
| 3 | MYGN |
Myriad Genetics Inc
|
107,783 | $615,440 | |
| 4 | GH |
Guardant Health, Inc.
This page
|
2,620 | $393,078 | |
| 5 | VCYT |
Veracyte, Inc.
|
6,192 | $363,656 | |
| 6 | NEO |
Neogenomics Inc
|
19,811 | $289,042 | |
| 7 | GRAL |
GRAIL, Inc.
|
3,982 | $271,851 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,196 | $271,240 |
All Filings in GH
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $393,078 | 2,620 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $704,598 | 7,628 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,085,339 | 10,626 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $671,472 | 10,747 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $566,715 | 10,890 | Shares | Sole | 2025-08-19 | |
| 2022-03-31 | $1,059 | 16 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,402 | 134 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $16,001 | 128 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $28,191 | 227 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $9,616 | 63 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||